Cox Pharmaceutical Ltd in London, N3 2JU

Description

Data updated on: 01-11-2023

This firm operates as Cox Pharmaceutical Ltd. It was started 14 years ago and was registered with 07133146 as the registration number. The office of the firm is situated in London. You may find it at Elscot House, Arcadia Avenue. The enterprise's Standard Industrial Classification Code is 21100 meaning Manufacture of basic pharmaceutical products. Cox Pharmaceutical Limited filed its account information for the financial year up to January 31, 2023. The most recent confirmation statement was submitted on July 21, 2023.

At the moment, the directors chosen by this company are as follow: Ibraheem A. arranged to perform management duties in 2013 in September and Taife A. arranged to perform management duties fourteen years ago.

Executives who control the firm include: Ibraheem A. owns over 1/2 to 3/4 of company shares . Taife A. owns 1/2 or less of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-01-31	2012-01-31	2013-01-31	2014-01-31	2015-01-31	2016-01-31	2017-01-31	2018-01-31	2019-01-31	2020-01-31	2021-01-31	2022-01-31	2023-01-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	-4 332	-33 980	-1 302	-333 989	-300 099	-1 092 184	-1 331 138

Balance Sheet
Cash Bank In Hand	5 412	9 543	3 815	69 420	33 844	47 313
Current Assets	5 412	470 863	465 135	530 740	776 792	637 784	528 860	509 324	521 739	412 870	342 598	359 471	347 415
Net Assets Liabilities Including Pension Asset Liability	-4 332	-33 980	-1 302	-333 989	-267 197	-1 092 184	-1 331 138
Net Assets Liabilities							1 331 138	1 576 995	1 797 660	2 026 568	2 099 794	2 083 283	2 136 922
Debtors					291 627	238 087
Stocks Inventory		461 320	461 320	461 320	461 320	352 384

Capital & Reserves
Called Up Share Capital	1	1	1	1	1	10 000
Profit Loss Account Reserve	-4 333	-33 981	-1 303	-333 990	-267 198	-1 102 184
Shareholder Funds	-4 332	-33 980	-1 302	-333 989	-300 099	-1 092 184	-1 331 138

Other Financial Data
Creditors Due After One Year Total Noncurrent Liabilities	9 121	375 803
Creditors Due Within One Year Total Current Liabilities	623	346 709
Net Current Assets Liabilities	4 789	470 863	431 817	510 170	756 222	611 954	503 029	478 953	482 658	371 118	300 714	317 587	304 948
Total Assets Less Current Liabilities	4 789	470 863	431 817	510 170	766 221	611 953	517 999	492 143	492 143	374 302	301 076	317 587	304 948
Average Number Employees During Period									3	3	3	3	3
Creditors							25 830	30 371	39 081	41 752	41 884	41 884	42 467
Fixed Assets							14 970	13 190	9 485	3 184	362
Creditors Due After One Year		504 843	433 119	844 159	1 066 320	1 704 138	1 849 137
Creditors Due Within One Year			33 318	20 570	20 570	25 831	25 831
Instalment Debts Due After5 Years			433 119	844 159
Number Shares Allotted				1
Par Value Share				1
Share Capital Allotted Called Up Paid			1	1

Company staff

Ibraheem A.

Role: Director

Appointed: 01 September 2013

Latest update: 7 May 2024

Taife A.

Role: Director

Appointed: 31 March 2010

Latest update: 7 May 2024

People with significant control

Ibraheem A.

Notified on 1 January 2017

Nature of control:

over 1/2 to 3/4 of shares

Taife A.

Notified on 1 January 2017

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	31 October 2024
Account last made up date	31 January 2023
Confirmation statement next due date	04 August 2024
Confirmation statement last made up date	21 July 2023

Annual Accounts 31 March 2013
Start Date For Period Covered By Report	2012-02-01
End Date For Period Covered By Report	2013-01-31
Date Approval Accounts	31 March 2013
Annual Accounts 31 March 2014
Start Date For Period Covered By Report	2013-02-01
Date Approval Accounts	31 March 2014
Annual Accounts
Start Date For Period Covered By Report	2014-02-01
End Date For Period Covered By Report	2015-01-31
Annual Accounts 26 October 2016
Start Date For Period Covered By Report	2015-02-01
Date Approval Accounts	26 October 2016
Annual Accounts
Start Date For Period Covered By Report	2016-02-01
Annual Accounts
Start Date For Period Covered By Report	2017-02-01
End Date For Period Covered By Report	2018-01-31
Annual Accounts
Start Date For Period Covered By Report	2018-02-01
End Date For Period Covered By Report	2019-01-31
Annual Accounts
Start Date For Period Covered By Report	2019-02-01
End Date For Period Covered By Report	2020-01-31
Annual Accounts
Start Date For Period Covered By Report	2020-02-01
End Date For Period Covered By Report	2021-01-31
Annual Accounts
Start Date For Period Covered By Report	2021-02-01
End Date For Period Covered By Report	2022-01-31
Annual Accounts
Start Date For Period Covered By Report	2022-02-01
End Date For Period Covered By Report	2023-01-31
Annual Accounts
End Date For Period Covered By Report	2014-01-31
Annual Accounts
End Date For Period Covered By Report	2016-01-31
Annual Accounts 12 October 2017
End Date For Period Covered By Report	2017-01-31
Date Approval Accounts	12 October 2017
Annual Accounts 30 October 2015
Date Approval Accounts	30 October 2015

Cox Pharmaceutical Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Ibraheem A.

Taife A.

Michael G.

People with significant control

Ibraheem A.

Taife A.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies